These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 20812768

  • 21. Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry.
    Cortese S, Panei P, Arcieri R, Germinario EA, Capuano A, Margari L, Chiarotti F, Curatolo P.
    CNS Drugs; 2015; 29(10):865-77. PubMed ID: 26293742
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults.
    Santosh PJ, Sattar S, Canagaratnam M.
    CNS Drugs; 2011 Sep 01; 25(9):737-63. PubMed ID: 21870887
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effects of atomoxetine on cardiovascular functions and on QT dispersion in children with attention deficit hyperactivity disorder.
    Sert A, Gokcen C, Aypar E, Odabas D.
    Cardiol Young; 2012 Apr 01; 22(2):158-61. PubMed ID: 21864451
    [Abstract] [Full Text] [Related]

  • 26. Attention deficit hyperactivity disorder in adults.
    Rösler M, Casas M, Konofal E, Buitelaar J.
    World J Biol Psychiatry; 2010 Aug 01; 11(5):684-98. PubMed ID: 20521876
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions.
    Yildiz O, Sismanlar SG, Memik NC, Karakaya I, Agaoglu B.
    Child Psychiatry Hum Dev; 2011 Jun 01; 42(3):257-69. PubMed ID: 21165694
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder.
    Ni HC, Shang CY, Gau SS, Lin YJ, Huang HC, Yang LK.
    Int J Neuropsychopharmacol; 2013 Oct 01; 16(9):1959-73. PubMed ID: 23672818
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. ADHD update: new data on the risks of medication.
    Harv Ment Health Lett; 2006 Oct 01; 23(4):3-5. PubMed ID: 17183739
    [No Abstract] [Full Text] [Related]

  • 37. Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine.
    Roskell NS, Setyawan J, Zimovetz EA, Hodgkins P.
    Curr Med Res Opin; 2014 Aug 01; 30(8):1673-85. PubMed ID: 24627974
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Exposure to attention deficit hyperactivity disorder medications during pregnancy.
    Humphreys C, Garcia-Bournissen F, Ito S, Koren G.
    Can Fam Physician; 2007 Jul 01; 53(7):1153-5. PubMed ID: 17872810
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.